Antithrombotic and Anticoagulant Profiles of TAK-442, a Novel Factor Xa Inhibitor, in a Rabbit Model of Venous Thrombosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antithrombotic and Anticoagulant Profiles of TAK-442, a Novel Factor Xa Inhibitor, in a Rabbit Model of Venous Thrombosis

Published:2010-08 Issue:2 Volume:56 Page:156-161
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Kawamura Masaki,Konishi Noriko,Hiroe Katsuhiko,Shofuda Ken-ichi,Imaeda Yasuhiro,Fujimoto Takuya,Kubo Keiji

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference15 articles.

1. Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th Edition).;Ansell;Chest,2008

2. Ximelagatran, the new oral anticoagulant: would warfarin survive the challenge?;Mousa;Cardiovasc Drug Rev,2005

3. Dabigatran Etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.;Baetz;Pharmacotherapy,2008

4. Yusuf S, et al; the RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation.;Connolly;N Engl J Med,2009

5. The new oral anticoagulants.;Garcia;Blood,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAK-442, a Direct Factor Xa Inhibitor, Inhibits Monocyte Chemoattractant Protein 1 Production in Endothelial Cells via Involvement of Protease-Activated Receptor 1;Frontiers in Pharmacology;2018-12-04

2. Anti-thrombotic effect of a factor Xa inhibitor TAK-442 in a rabbit model of arteriovenous shunt thrombosis stimulated with tissue factor;BMC Research Notes;2018-10-30

3. New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds;Expert Opinion on Investigational Drugs;2017-12-14

4. Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome;Thrombosis and Haemostasis;2014

5. Newer Anticoagulants in Cardiovascular Disease;Cardiology in Review;2012-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3